Sex-Based Differences in Cardiometabolic Biomarkers

Jeanney Lew, Monika Sanghavi, Colby R. Ayers, Darren K McGuire, Torbjørn Omland, Dorothee Atzler, Maria O. Gore, Ian J Neeland, Jarett D Berry, Amit Khera, Anand K Rohatgi, James A de Lemos

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Background: Few data are available comparing cardiovascular disease (CVD) biomarker profiles between women and men in the general population. We analyzed sex-based differences in multiple biomarkers reflecting distinct pathophysiological pathways, accounting for differences between women and men in CVD risk factors, body composition, and cardiac morphology. Methods: A cross-sectional analysis was performed using data from the Dallas Heart Study, a multiethnic population-based study. Associations between sex and 30 distinct biomarkers representative of 6 pathophysiological categories were evaluated using multivariable linear regression adjusting for age, race, traditional CVD risk factors, kidney function, insulin resistance, MRI and dual-energy x-ray absorptiometry measures of body composition and fat distribution, and left ventricular mass. Results: After excluding participants with CVD, the study population included 3439 individuals, mean age 43 years, 56% women, and 52% black. Significant sex-based differences were seen in multiple categories of biomarkers, including lipids, adipokines, and biomarkers of inflammation, endothelial dysfunction, myocyte injury and stress, and kidney function. In fully adjusted models, women had higher levels of high-density lipoprotein cholesterol and high-density lipoprotein particle concentration, leptin, d-dimer, homoarginine, and N-Terminal pro B-Type natriuretic peptide, and lower levels of low-density lipoprotein cholesterol, adiponectin, lipoprotein-Associated phospholipase A2 mass and activity, monocyte chemoattractant protein-1, soluble endothelial cell adhesion molecule, symmetrical dimethylarginine, asymmetrical dimethylarginine, high-sensitivity troponin T, and cystatin C. Conclusions: Biomarker profiles differ significantly between women and men in the general population. Sex differences were most apparent for biomarkers of adiposity, endothelial dysfunction, inflammatory cell recruitment, and cardiac stress and injury. Future studies are needed to characterize whether pathophysiological processes delineated by these biomarkers contribute to sex-based differences in the development and complications of CVD.

Original languageEnglish (US)
Pages (from-to)544-555
Number of pages12
JournalCirculation
Volume135
Issue number6
DOIs
StatePublished - Feb 7 2017

Fingerprint

Sex Characteristics
Biomarkers
Cardiovascular Diseases
Body Composition
Population
Homoarginine
1-Alkyl-2-acetylglycerophosphocholine Esterase
Troponin C
Body Fat Distribution
Kidney
Cystatin C
Troponin T
Adipokines
Chemokine CCL2
Brain Natriuretic Peptide
Adiponectin
Adiposity
Wounds and Injuries
Cell Adhesion Molecules
HDL Lipoproteins

Keywords

  • biomarkers
  • body composition
  • cardiovascular diseases
  • menopause
  • sex
  • women

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Sex-Based Differences in Cardiometabolic Biomarkers. / Lew, Jeanney; Sanghavi, Monika; Ayers, Colby R.; McGuire, Darren K; Omland, Torbjørn; Atzler, Dorothee; Gore, Maria O.; Neeland, Ian J; Berry, Jarett D; Khera, Amit; Rohatgi, Anand K; de Lemos, James A.

In: Circulation, Vol. 135, No. 6, 07.02.2017, p. 544-555.

Research output: Contribution to journalArticle

Lew, Jeanney ; Sanghavi, Monika ; Ayers, Colby R. ; McGuire, Darren K ; Omland, Torbjørn ; Atzler, Dorothee ; Gore, Maria O. ; Neeland, Ian J ; Berry, Jarett D ; Khera, Amit ; Rohatgi, Anand K ; de Lemos, James A. / Sex-Based Differences in Cardiometabolic Biomarkers. In: Circulation. 2017 ; Vol. 135, No. 6. pp. 544-555.
@article{eda62c1b09544ff4839149f3caf98160,
title = "Sex-Based Differences in Cardiometabolic Biomarkers",
abstract = "Background: Few data are available comparing cardiovascular disease (CVD) biomarker profiles between women and men in the general population. We analyzed sex-based differences in multiple biomarkers reflecting distinct pathophysiological pathways, accounting for differences between women and men in CVD risk factors, body composition, and cardiac morphology. Methods: A cross-sectional analysis was performed using data from the Dallas Heart Study, a multiethnic population-based study. Associations between sex and 30 distinct biomarkers representative of 6 pathophysiological categories were evaluated using multivariable linear regression adjusting for age, race, traditional CVD risk factors, kidney function, insulin resistance, MRI and dual-energy x-ray absorptiometry measures of body composition and fat distribution, and left ventricular mass. Results: After excluding participants with CVD, the study population included 3439 individuals, mean age 43 years, 56{\%} women, and 52{\%} black. Significant sex-based differences were seen in multiple categories of biomarkers, including lipids, adipokines, and biomarkers of inflammation, endothelial dysfunction, myocyte injury and stress, and kidney function. In fully adjusted models, women had higher levels of high-density lipoprotein cholesterol and high-density lipoprotein particle concentration, leptin, d-dimer, homoarginine, and N-Terminal pro B-Type natriuretic peptide, and lower levels of low-density lipoprotein cholesterol, adiponectin, lipoprotein-Associated phospholipase A2 mass and activity, monocyte chemoattractant protein-1, soluble endothelial cell adhesion molecule, symmetrical dimethylarginine, asymmetrical dimethylarginine, high-sensitivity troponin T, and cystatin C. Conclusions: Biomarker profiles differ significantly between women and men in the general population. Sex differences were most apparent for biomarkers of adiposity, endothelial dysfunction, inflammatory cell recruitment, and cardiac stress and injury. Future studies are needed to characterize whether pathophysiological processes delineated by these biomarkers contribute to sex-based differences in the development and complications of CVD.",
keywords = "biomarkers, body composition, cardiovascular diseases, menopause, sex, women",
author = "Jeanney Lew and Monika Sanghavi and Ayers, {Colby R.} and McGuire, {Darren K} and Torbj{\o}rn Omland and Dorothee Atzler and Gore, {Maria O.} and Neeland, {Ian J} and Berry, {Jarett D} and Amit Khera and Rohatgi, {Anand K} and {de Lemos}, {James A}",
year = "2017",
month = "2",
day = "7",
doi = "10.1161/CIRCULATIONAHA.116.023005",
language = "English (US)",
volume = "135",
pages = "544--555",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Sex-Based Differences in Cardiometabolic Biomarkers

AU - Lew, Jeanney

AU - Sanghavi, Monika

AU - Ayers, Colby R.

AU - McGuire, Darren K

AU - Omland, Torbjørn

AU - Atzler, Dorothee

AU - Gore, Maria O.

AU - Neeland, Ian J

AU - Berry, Jarett D

AU - Khera, Amit

AU - Rohatgi, Anand K

AU - de Lemos, James A

PY - 2017/2/7

Y1 - 2017/2/7

N2 - Background: Few data are available comparing cardiovascular disease (CVD) biomarker profiles between women and men in the general population. We analyzed sex-based differences in multiple biomarkers reflecting distinct pathophysiological pathways, accounting for differences between women and men in CVD risk factors, body composition, and cardiac morphology. Methods: A cross-sectional analysis was performed using data from the Dallas Heart Study, a multiethnic population-based study. Associations between sex and 30 distinct biomarkers representative of 6 pathophysiological categories were evaluated using multivariable linear regression adjusting for age, race, traditional CVD risk factors, kidney function, insulin resistance, MRI and dual-energy x-ray absorptiometry measures of body composition and fat distribution, and left ventricular mass. Results: After excluding participants with CVD, the study population included 3439 individuals, mean age 43 years, 56% women, and 52% black. Significant sex-based differences were seen in multiple categories of biomarkers, including lipids, adipokines, and biomarkers of inflammation, endothelial dysfunction, myocyte injury and stress, and kidney function. In fully adjusted models, women had higher levels of high-density lipoprotein cholesterol and high-density lipoprotein particle concentration, leptin, d-dimer, homoarginine, and N-Terminal pro B-Type natriuretic peptide, and lower levels of low-density lipoprotein cholesterol, adiponectin, lipoprotein-Associated phospholipase A2 mass and activity, monocyte chemoattractant protein-1, soluble endothelial cell adhesion molecule, symmetrical dimethylarginine, asymmetrical dimethylarginine, high-sensitivity troponin T, and cystatin C. Conclusions: Biomarker profiles differ significantly between women and men in the general population. Sex differences were most apparent for biomarkers of adiposity, endothelial dysfunction, inflammatory cell recruitment, and cardiac stress and injury. Future studies are needed to characterize whether pathophysiological processes delineated by these biomarkers contribute to sex-based differences in the development and complications of CVD.

AB - Background: Few data are available comparing cardiovascular disease (CVD) biomarker profiles between women and men in the general population. We analyzed sex-based differences in multiple biomarkers reflecting distinct pathophysiological pathways, accounting for differences between women and men in CVD risk factors, body composition, and cardiac morphology. Methods: A cross-sectional analysis was performed using data from the Dallas Heart Study, a multiethnic population-based study. Associations between sex and 30 distinct biomarkers representative of 6 pathophysiological categories were evaluated using multivariable linear regression adjusting for age, race, traditional CVD risk factors, kidney function, insulin resistance, MRI and dual-energy x-ray absorptiometry measures of body composition and fat distribution, and left ventricular mass. Results: After excluding participants with CVD, the study population included 3439 individuals, mean age 43 years, 56% women, and 52% black. Significant sex-based differences were seen in multiple categories of biomarkers, including lipids, adipokines, and biomarkers of inflammation, endothelial dysfunction, myocyte injury and stress, and kidney function. In fully adjusted models, women had higher levels of high-density lipoprotein cholesterol and high-density lipoprotein particle concentration, leptin, d-dimer, homoarginine, and N-Terminal pro B-Type natriuretic peptide, and lower levels of low-density lipoprotein cholesterol, adiponectin, lipoprotein-Associated phospholipase A2 mass and activity, monocyte chemoattractant protein-1, soluble endothelial cell adhesion molecule, symmetrical dimethylarginine, asymmetrical dimethylarginine, high-sensitivity troponin T, and cystatin C. Conclusions: Biomarker profiles differ significantly between women and men in the general population. Sex differences were most apparent for biomarkers of adiposity, endothelial dysfunction, inflammatory cell recruitment, and cardiac stress and injury. Future studies are needed to characterize whether pathophysiological processes delineated by these biomarkers contribute to sex-based differences in the development and complications of CVD.

KW - biomarkers

KW - body composition

KW - cardiovascular diseases

KW - menopause

KW - sex

KW - women

UR - http://www.scopus.com/inward/record.url?scp=85012085357&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012085357&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.116.023005

DO - 10.1161/CIRCULATIONAHA.116.023005

M3 - Article

C2 - 28153991

AN - SCOPUS:85012085357

VL - 135

SP - 544

EP - 555

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 6

ER -